In 2023, Transparency International worked as a united, global force for change. We have one vision: a world in which government, business, civil society and the daily lives of people are free of ...

Former President Donald Trump and President Joe Biden were both asked about fatal drug overdoses and addiction during the CNN Presidential Debate Thursday, touching on a years-long epidemic that has ...

A tech-wide reckoning that began in 2022 and ran throughout into 2023. Though 2024 has gotten off to a rough start, it has yet to reach the peak of the prior year’s substantial cutbacks. This post ...

More than a million abortions were provided in the U.S. in 2023. That's a major finding from a report published Tuesday by the Guttmacher Institute, a research organization that supports access to ...

At least 117,492 people were murdered in Latin America and the Caribbean during 2023, putting the median homicide rate around 20 per 100,000 people. But homicide data in many countries is missing or ...

The season is over. A champion has been crowned. All that's left is to deliver a final, comprehensive ranking of every quarterback who started a game in 2023, judging them by the entire regular season ...

This article was written by Jonathan Gardiner, Sustainable Indices Product Manager, and Tom Freke, Fixed Income Data Specialist at Bloomberg. Sustainable bond issuance topped more than a trillion ...

The U.S. set another grim record last year as the number of people killed by police continued its steady increase, according to a new report released Wednesday by Mapping Police Violence. The number ...

Women authors fared very well at the top of the PW overall bestseller list in 2023. Colleen Hoover, who reigned supreme in 2022, also had a stellar 2023, with her It Ends with Us edging out It Starts ...

The U.S. labor market ended the year strong, creating more than 200,000 jobs in the last month of the year and nearly 2.7 million jobs in all of 2023, when seasonally adjusted. Consumer spending ...

Hot on the heels of the COVID-19 vaccine success story (including updated jabs that target Omicron subvariants of the rapidly shifting virus), 2023 saw the greenlighting of several new vital vaccines.

The FDA’s Center for Drug Evaluation and Research (CDER) approved 55 new drugs in 2023, as the small molecule and biologic pharmacopoeia continues to grow. This cohort is nearly 50% bigger than the ...